PUS7 and glioblastoma: Predicted loss of function and missense mutations in the catalytic domain of PUS7 lead to neurodevelopmental disorders and have been linked to age-related macular degeneration20–26, while aberrant overexpression of PUS7 promotes glioblastoma tumorigenesis in a manner dependent on PUS7’s catalytic activity17.